NCT05978167View on ClinicalTrials.gov

Targeting Drug Memories With Methylphenidate

EARLY_PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

July 5, 2023

Primary Completion Date

September 3, 2026

Study Completion Date

September 3, 2026

Conditions
Substance Use DisorderCocaine Use Disorder
Interventions
DRUG

Methylphenidate

Oral administration of 20 mg Methylphenidate

BEHAVIORAL

Memory reconsolidation

Retrieval of drug-cue memories before extinction.

DRUG

Placebo

Matching placebo pill

Trial Locations (1)

10029

Icahn School of Medicine at Mount Sinai, New York

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Icahn School of Medicine at Mount Sinai

OTHER